このページには最新15件を掲載。
それ以前のものは年別に下端リンク先を参照。
-
Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
Chisato Saeki, Tsunekazu Oikawa, Kaoru Ueda, Masanori Nakano, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota
Diagnostics (Basel) . 2022 Aug 12;12(8):1957. Aug 12, 2022 DOI:10.3390/diagnostics12081957 -
Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD)
Masayuki Saruta et al.
J Gastroenterol . 2022 Aug 5. Aug 05, 2022 DOI:10.1007/s00535-022-01907-2 -
Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study
Kaoru Ueda, Yoshio Aizawa, Chika Kinoshita, Tomohisa Nagano, Jinya Ishida, Chisato Saeki, Tsunekazu Oikawa, Toru Harada, Atsushi Hokari, Masayuki Saruta
Medicine (Baltimore) . 2022 Jul 22;101(29):e29484 Jul 22, 2022 DOI:10.1097/MD.0000000000029484. -
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon ～
Masayuki Saruta et al.
Int J Clin Oncol . 2022 Jul 21 Jul 21, 2022 DOI:10.1007/s10147-022-02208-7 -
Safety and efficacy of pentazocine-midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma
Masanori Nakano, Yuichi Torisu, Chika Nakagawa, Kaoru Ueda, Tomoya Kanai, Chisato Saeki, Tsunekazu Oikawa, Masayuki Saruta
JGH Open . 2022 Jul 17;6(8):569-576 Jul 17, 2022 DOI:10.1002/jgh3.12788 -
Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial
Masayuki Saruta et al
J Gastroenterol Hepatol . 2022 Jul 15 Jul 15, 2022 DOI:10.1111/jgh.15945 -
Bowel frequency (night) and urgent defecation are improved by budesonide foam in patients with ulcerative colitis: a retrospective observational study
Ryosuke Miyazaki, Toshiyuki Sakurai, Mariko Shimada, Yuko Iwashita, Naoki Shibuya, Yoshihiro Akita, Haruna Miyashita, Yuki Maruyama, Masayuki Saruta
BMC Gastroenterol . 2022 Jun 24;22(1):310 Jun 24, 2022 DOI:10.1186/s12876-022-02388-6 -
The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions
Shigeo Koido, Sankichi Horiuchi, Shin Kan, Tsuuse Bito, Zensho Ito, Kan Uchiyama, Masayuki Saruta, Nobuhiro Sato, Toshifumi Ohkusa
Sci Rep . 2022 Jun 23;12(1):10698 Jun 23, 2022 DOI:10.1038/s41598-022-14934-z. -
Efficacy of the pocket-creation method with a traction device in endoscopic submucosal dissection for residual or recurrent colorectal lesions
Daisuke Ide, Tomohiko Richard Ohya, Mitsuaki Ishioka, Yuri Enomoto, Eisuke Nakao, Yuki Mitsuyoshi, Junki Tokura, Keigo Suzuki, Seiichi Yakabi, Chihiro Yasue, Akiko Chino, Masahiro Igarashi, Akio Nakashima, Masayuki Saruta, Shoichi Saito, Junko Fujisaki
Clin Endosc May 31, 2022 DOI:10.5946/ce.2022.009. -
Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
Chisato Saeki, Juntaro Matsuzaki, Masahiko Kuroda, Koji Fujita, Makiko Ichikawa, Satoko Takizawa, Keiko Takano, Tsunekazu Oikawa, Yasuni Nakanuma, Masayuki Saruta, Takahiro Ochiya, Akihito Tsubota
BMJ Open Gastroenterol . 2022 Apr;9(1) Apr 09, 2022 DOI:10.1136/bmjgast-2022-000879.